Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2023-12-18 Declaration of Voting R…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Proceedings of the meeting of the equity shareholders convened pursuant to the order passed by the NCLT. Refer enclosed file for details.
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed account of the proceedings of a meeting of equity shareholders convened pursuant to an order by the National Company Law Tribunal (NCLT). It includes information about the meeting's agenda, attendance, quorum, discussions, and voting procedures related to a scheme of arrangement involving a demerger. The document is addressed to stock exchanges and references compliance with SEBI (LODR) Regulations. It does not contain financial statements or results but rather the minutes and proceedings of a shareholder meeting. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports on the meeting proceedings and mentions that voting results will be declared soon. The document is not merely an announcement of a report but the actual detailed proceedings. Therefore, the appropriate classification is DVA with high confidence.
2023-12-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges regarding an order passed by a government authority (Office of the Commissioner, Central GST & Central Excise) related to disallowance of Cenvat Credit and penalties. It is submitted under Regulation 30 of SEBI (LODR) Regulations, which pertains to disclosure of material events. The document does not contain financial statements or detailed financial analysis but is an announcement of a regulatory/legal order affecting the company. It is not an annual report, audit report, earnings release, or any financial report. It is a regulatory announcement about a legal proceeding/order impacting the company. Therefore, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters and is a disclosure letter, not a report itself.
2023-12-14 English
Announcement under Regulation 30
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order passed by a government authority (Office of the Commissioner, Central GST & Central Excise) regarding disallowance of Cenvat Credit and penalties. The document is a notification of a regulatory/legal event impacting the company, with no financial statements or detailed financial analysis included. The length is 3736 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. It does not contain financial results, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-12-14 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references SEBI regulations and a SEBI circular but does not contain financial data, earnings, management discussion, or any report content. It is an official notification about share certificate replacement, which relates to shareholding records but is not a major shareholding notification or a capital change announcement. It is a regulatory compliance communication informing the exchanges of administrative action taken by the company. Given the nature and length of the document, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-12-14 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references SEBI regulations and a SEBI circular but does not contain financial data, earnings, management discussion, or any report content. It is an announcement related to share certificates, which falls under regulatory compliance disclosures. The document length is short (1764 characters), and it is not a report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-13 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document contains multiple public notices, including a notice to equity shareholders and unsecured creditors regarding a Scheme of Arrangement with a meeting scheduled for December 18, 2023. It also includes details about the appointed date for the scheme and references to the National Company Law Tribunal order. The document is primarily an announcement of the notice publication and meeting details rather than the full scheme document or detailed financial reports. The length is about 15,000 characters, but the content is mostly notices and announcements rather than substantive financial data or management discussion. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement and notice to shareholders about an upcoming meeting and scheme consideration, not the actual scheme document or a full report.
2023-12-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.